Idexx Laboratories (IDXX) Stock Price, Quote & News

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 207 556 0300

Fax: 207 556 4346

Website: www.idexx.com

Address:

One IDEXX Drive, Westbrook, United States

Arcides May. 11 at 5:02 PM

$IDXX another health care stock with new breakdown...

0 · Reply

BillionerOfKing May. 11 at 4:44 PM

$IDXX Current Stock Price: $536.65 Contracts to trade: $540.0 IDXX May 15 2026 Call Entry: $6.30 Exit: $9.98 ROI: 58% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

BillionerOfKing May. 6 at 10:31 PM

$IDXX Current Stock Price: $579.23 Contracts to trade: $580.0 IDXX May 15 2026 Call Entry: $11.20 Exit: $18.62 ROI: 66% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Estimize May. 5 at 6:24 PM

$IDXX reported 3.47 EPS and 1,141 revenue for Q1. http://www.estimize.com/intro/idxx?chart=historical&metric_name=eps&utm_content=IDXX&utm_

0 · Reply

StocktwitsEarnings May. 5 at 10:38 AM

$IDXX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $3.50 up 17.45% YoY • Reported revenue of $1.14B up 14.26% YoY • Idexx Laboratories increased its 2026 revenue guidance to $4.68B - $4.76B, reflecting stronger CAG Diagnostics performance. The company also raised its 2026 EPS outlook to $14.45 - $14.90 and projected operating margin expansion to 50-90 basis points.

0 · Reply

CapitalMonk May. 4 at 1:15 PM

$IDXX Price: $567.46 (+1.19%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.22% RSI: 47.7 | Momentum: Moderate Volume: +14.5% vs avg Volatility: 2.07% Support: $544.01 | Resistance: $605.82 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

topstockalerts Apr. 28 at 12:15 PM

Pre Market Top Gainers PT2 $NEXR $NDRA $IDXX $DDI $LGIH

0 · Reply

topstockalerts Apr. 28 at 10:58 AM

Pre Market Top Gainers $DRCT $PFSA $KIDZ $NWGL $IDXX

0 · Reply

SuperGreenToday Apr. 28 at 1:21 AM

$IDXX Share Price: $575.16 Contract Selected: Oct 16, 2026 $580 Calls Buy Zone: $48.02 – $59.33 Target Zone: $84.39 – $103.14 Potential Upside: 66% ROI Time to Expiration: 171 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

roblake29 Apr. 22 at 5:04 PM

$IDXX $ZTS Here's a link to my latest analysis, a deep-dive comparison of Idexx Labs and Zoetis. Interestingly, they both get a buy rating from me, but for different reasons. Constructive feedback welcome: https://seekingalpha.com/article/4892880-idexx-laboratories-vs-zoetis-a-pre-earnings-comparison

0 · Reply

Idexx Laboratories price target lowered to $660 from $790 at BofA

May 5, 2026, 8:30 AM EDT - 8 days ago

IDEXX Laboratories Earnings Call Transcript: Q1 2026

2026-05-05T10:53:57.000Z - 8 days ago

Idexx Laboratories reports Q1 EPS $3.47, consensus $3.41

2026-05-05T10:51:27.000Z - 8 days ago

Idexx Laboratories raises FY26 EPS view to $14.45-$14.90 from $14.29-$14.80

May 5, 2026, 6:30 AM EDT - 8 days ago

IDEXX Laboratories Announces First Quarter Results

2026-04-28T13:14:55.000Z - 15 days ago

Idexx Laboratories price target lowered to $640 from $730 at UBS

Apr 27, 2026, 11:40 AM EDT - 15 days ago

University of New England launches new Institute of Public and Planetary Health in honor of philanthropist and IDEXX Founder David Evans Shaw

2026-04-15T10:26:57.000Z - 4 weeks ago

Idexx Laboratories initiated with a Neutral at Citi

Apr 8, 2026, 1:00 PM EDT - 4 weeks ago

IDEXX Laboratories to Release 2026 First Quarter Financial Results

2026-04-01T09:15:31.000Z - 6 weeks ago

Idexx Laboratories announces Idexx Cancer Dx Panel availability in the UK

Apr 1, 2026, 3:00 AM EDT - 6 weeks ago

IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma

2026-03-31T10:44:57.000Z - 6 weeks ago

Idexx Laboratories price target lowered to $675 from $775 at Stifel

2026-03-26T19:45:14.000Z - 6 weeks ago

Idexx Laboratories management to meet with Piper Sandler

Mar 2, 2026, 9:15 AM EST - 2 months ago

IDEXX Laboratories Transcript: 47th Annual Raymond James Institutional Investor Conference

Feb 26, 2026, 9:50 AM EST - 2 months ago

IDEXX Laboratories Transcript: BofA Securities Animal Health Summit

Feb 12, 2026, 4:15 PM EST - 3 months ago

IDEXX Laboratories to Present at Two Institutional Investor Conferences

2026-02-09T11:55:29.000Z - 3 months ago

Idexx Laboratories price target lowered to $750 from $775 at Piper Sandler

2026-02-05T10:45:55.000Z - 3 months ago

Idexx Laboratories price target lowered to $800 from $850 at Barclays

2026-02-03T12:10:52.000Z - 3 months ago

Idexx Laboratories price target lowered to $730 from $750 at UBS

2026-02-03T02:10:10.000Z - 3 months ago

Idexx Laboratories price target lowered to $800 from $830 at BTIG

Feb 2, 2026, 8:30 AM EST - 3 months ago

IDEXX Laboratories Earnings Call Transcript: Q4 2025

Feb 2, 2026, 8:12 AM EST - 3 months ago

IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics

2026-02-02T12:05:15.000Z - 3 months ago

Options Volatility and Implied Earnings Moves Today, February 02, 2026

APTV ARLP DIS NXPI PLTR SPG TER

2026-02-02T11:35:45.000Z - 3 months ago

Idexx Laboratories reports Q4 EPS $3.08, consensus $2.94

2026-02-02T11:35:23.000Z - 3 months ago

Idexx Laboratories sees FY26 EPS $14.29-$14.80, consensus $14.45

Feb 2, 2026, 6:30 AM EST - 3 months ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

Jan 15, 2026, 7:15 AM EST - 4 months ago

Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus

Jan 15, 2026, 7:00 AM EST - 4 months ago

IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs

2026-01-13T14:01:18.000Z - 4 months ago

Idexx CEO Jonathan Mazelsky to switch to chairman, Michael Erickson to succeed

Jan 13, 2026, 8:30 AM EST - 4 months ago

IDEXX Announces CEO Succession

Jan 9, 2026, 1:30 PM EST - 4 months ago

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

Jan 7, 2026, 1:51 PM EST - 4 months ago

Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB

COF PANW XLB

Nov 24, 2025, 2:15 PM EST - 6 months ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

RMD

Nov 3, 2025, 1:29 PM EST - 6 months ago

Final Trades: Meta, S&P Global and Idexx Lab

META SPGI

Nov 3, 2025, 11:08 AM EST - 6 months ago

Idexx Stock Pops on Earnings. Pet Health Is Booming.

Nov 3, 2025, 8:30 AM EST - 6 months ago

IDEXX Laboratories Earnings Call Transcript: Q3 2025

Nov 3, 2025, 7:43 AM EST - 6 months ago

IDEXX raises annual forecasts as pet owners spend more on preventive care

Nov 3, 2025, 6:30 AM EST - 6 months ago

IDEXX Laboratories Announces Third Quarter Results

Oct 8, 2025, 2:00 PM EDT - 7 months ago

IDEXX Laboratories to Release 2025 Third Quarter Financial Results

Oct 7, 2025, 7:00 AM EDT - 7 months ago

IDEXX Laboratories Elects Karen Peacock to Board of Directors

Sep 9, 2025, 1:50 PM EDT - 8 months ago

IDEXX Laboratories Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 2, 2025, 1:00 PM EDT - 9 months ago

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 14, 2025, 8:00 AM EDT - 9 months ago

IDEXX Laboratories Transcript: Investor Day 2025

Aug 4, 2025, 5:55 PM EDT - 10 months ago

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

Aug 4, 2025, 1:48 PM EDT - 10 months ago

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

DAL IYF TSLA

Aug 4, 2025, 12:15 PM EDT - 10 months ago

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

Aug 4, 2025, 9:10 AM EDT - 10 months ago

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

Aug 4, 2025, 8:30 AM EDT - 10 months ago

IDEXX Laboratories Earnings Call Transcript: Q2 2025

Aug 4, 2025, 7:57 AM EDT - 10 months ago

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

Aug 4, 2025, 6:30 AM EDT - 10 months ago

IDEXX Laboratories Announces Second Quarter Results

Jul 30, 2025, 7:00 AM EDT - 10 months ago

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jul 10, 2025, 7:00 AM EDT - 10 months ago

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

Jun 24, 2025, 1:00 PM EDT - 11 months ago

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Jun 5, 2025, 7:00 AM EDT - 1 year ago

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

May 28, 2025, 10:55 AM EDT - 1 year ago

IDEXX Laboratories Transcript: Stifel Jaws & Paws Conference 2025

May 13, 2025, 2:30 PM EDT - 1 year ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

May 1, 2025, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q1 2025

May 1, 2025, 8:21 AM EDT - 1 year ago

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

Apr 3, 2025, 1:30 PM EDT - 1 year ago

IDEXX Laboratories to Release 2025 First Quarter Financial Results

Mar 3, 2025, 11:35 AM EST - 1 year ago

IDEXX Laboratories Transcript: Raymond James 46th Annual Institutional Investors Conference

Feb 27, 2025, 9:00 AM EST - 1 year ago

IDEXX Laboratories Transcript: BofA Securities Animal Health Summit 2025

Feb 13, 2025, 2:00 PM EST - 1 year ago

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

Feb 3, 2025, 11:31 AM EST - 1 year ago

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today's Top S&P 500 Performers.

ABBV MOH

Feb 3, 2025, 11:22 AM EST - 1 year ago

IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices

Feb 3, 2025, 8:30 AM EST - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q4 2024

Feb 3, 2025, 7:57 AM EST - 1 year ago

Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits

Feb 3, 2025, 6:30 AM EST - 1 year ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results

Jan 16, 2025, 4:15 PM EST - 1 year ago

IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results

Dec 19, 2024, 10:09 AM EST - 1 year ago

SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX

SNPS

Dec 9, 2024, 7:30 AM EST - 1 year ago

IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization

Nov 21, 2024, 7:30 AM EST - 1 year ago

IDEXX Announces CFO Transition

Nov 12, 2024, 9:00 AM EST - 1 year ago

ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents

Oct 31, 2024, 1:15 PM EDT - 1 year ago

CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results

Oct 31, 2024, 8:30 AM EDT - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q3 2024

Oct 31, 2024, 8:01 AM EDT - 1 year ago

IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow

Sep 30, 2024, 2:00 PM EDT - 1 year ago

IDEXX Laboratories to Release 2024 Third Quarter Financial Results

Sep 4, 2024, 11:30 AM EDT - 1 year ago

IDEXX Laboratories Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 21, 2024, 4:15 PM EDT - 1 year ago

IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 15, 2024, 8:00 AM EDT - 1 year ago

IDEXX Laboratories Transcript: Investor Day 2024

Aug 6, 2024, 9:00 AM EDT - 1 year ago

IDEXX Laboratories Earnings Call Transcript: Q2 2024

Jul 30, 2024, 5:53 PM EDT - 1 year ago

IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call

Jul 30, 2024, 7:00 AM EDT - 1 year ago

IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jun 24, 2024, 11:00 AM EDT - 2 years ago

IDEXX Laboratories to Release 2024 Second Quarter Financial Results

Arcides May. 11 at 5:02 PM

$IDXX another health care stock with new breakdown...

0 · Reply

BillionerOfKing May. 11 at 4:44 PM

0 · Reply

BillionerOfKing May. 6 at 10:31 PM

0 · Reply

Estimize May. 5 at 6:24 PM

$IDXX reported 3.47 EPS and 1,141 revenue for Q1. http://www.estimize.com/intro/idxx?chart=historical&metric_name=eps&utm_content=IDXX&utm_

0 · Reply

StocktwitsEarnings May. 5 at 10:38 AM

0 · Reply

CapitalMonk May. 4 at 1:15 PM

0 · Reply

topstockalerts Apr. 28 at 12:15 PM

Pre Market Top Gainers PT2 $NEXR $NDRA $IDXX $DDI $LGIH

0 · Reply

topstockalerts Apr. 28 at 10:58 AM

Pre Market Top Gainers $DRCT $PFSA $KIDZ $NWGL $IDXX

0 · Reply

SuperGreenToday Apr. 28 at 1:21 AM

0 · Reply

roblake29 Apr. 22 at 5:04 PM

0 · Reply

DonCorleone77 Apr. 7 at 11:40 AM

$ELAN $IDXX $ZTS $TRUP $CHWY Attached is a page from a Piper Sandler analyst report regarding ELAN, IDXX, ZTS, TRUP and CHWY issued 4.2.26

0 · Reply

txbondman Mar. 30 at 1:00 PM

bot $BABA, $CVCO, and $IDXX to double down; (Don't try this at home!!)

0 · Reply

MyChicago Mar. 27 at 9:24 PM

$ZOMDF Paul Tye, Great News to have Mr Tye on board. High Expectations for Zomedicas global expansion in their International Markets. Paul Tye was also with IDXX and Mars. $IDXX Excited to see the Premium Equine Market and Racing that Zomedica is built to serve with their diagnostics and therapeutics. The Stall Side ACTH test and Insulin level tests are truly a game changer, and Zomedica is the only company right now that offers this. There are 9.2 Million horses in the U.S.A. Zomedica has 53.3 Million dollars in cash. No Debt. Great Reduction in Cash Burn, I believe It is their lowest ever. Larry states they have enough cash to to accomplish their goals to profitability by end of this year or definitely next. He was very straight forward about this and feels certain that we will be cash flow positive Very Soon. There is not a better time buy. BULLISH.

0 · Reply

MyChicago Mar. 18 at 7:10 PM

$ZOMDF $IDXX : Built in‑clinic diagnostic platforms Created recurring consumables Locked in veterinary practices Expanded globally Focused on execution, not hype Sound familiar? HESKA was bought out by Mars a prive a company.

1 · Reply

MyChicago Mar. 18 at 4:17 PM

$ZOMDF $ZOMDF $IDXX Zomedica now runs a multi‑product veterinary platform — TRUFORMA, TRUVIEW, PulseVet, VETIGEL, Assisi Loop, VetGuardian — backed by partners like Boehringer Ingelheim, Qorvo, Moichor, Grovet, Cresilon, and BAW. That’s execution. That’s scale.

0 · Reply

MyChicago Mar. 18 at 1:38 PM

$ZOMDF Zomedica vs IDEXX Equine Diagnostics $IDXX IDEXX (Traditional Model): Centralized reference labs Send‑out testing Slower turnaround Less control for the clinic Zomedica + Boehringer (Modern Model): In‑clinic endocrine testing Same‑day results Ongoing monitoring revenue Integrated into treatment decisions IDEXX dominates labs. Zomedica is attacking point‑of‑care, where speed and workflow matter most. Different lanes — and Zomedica just got a global partner to help run theirs.

0 · Reply

Lambition Mar. 17 at 4:19 AM

$ZOMDF $BTC.X $SPY $GS $IDXX https://stocks.apple.com/Aa3cVWwYpR7u_ifLzHZzwgQ

0 · Reply

SuperGreenToday Mar. 11 at 1:28 PM

$IDXX Share Price: $598.63 Contract Selected: Oct 16, 2026 $610 Calls Buy Zone: $66.03 – $81.57 Target Zone: $105.53 – $128.99 Potential Upside: 51% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ZacksResearch Mar. 9 at 7:11 PM

$IDXX up 39% in a year — and the momentum isn’t random. CAG Diagnostics’ recurring revenues, ongoing diagnostic innovations, and software growth are fueling the run, helping push shares up 39% over the past year. 🚀 Discover what’s driving the surge 👉 https://www.zacks.com/stock/news/2881137/idexx-laboratories-stock-climbs-394-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2881137-teaser-36644&ADID=SYND_STOCKTWITS_TWEET_2_2881137_TEASER_36644

0 · Reply

ZacksResearch Mar. 9 at 6:11 PM

$IDXX surges 39.4% over the last 12 months — what’s fueling this rally? 🚀 📈 CAG Diagnostics’ recurring revenues up 10% organically in Q4 2025 🔬 Innovations like Cancer Dx panel and inVue Dx gaining traction 🌍 Expanding global commercial footprint enhances growth potential See what makes the investment case strong for IDXX 👉 https://www.zacks.com/stock/news/2881137/idexx-laboratories-stock-climbs-394-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2881137-body-36645&ADID=SYND_STOCKTWITS_TWEET_2_2881137_BODY_36645

0 · Reply

Villidj_Idjit Mar. 8 at 4:48 AM

$IDXX possible bullish divergence.

0 · Reply

Market Cap	41.97B
Revenue (ttm)	4.30B
Net Income (ttm)	1.06B
EPS (ttm)	N/A
PE Ratio	41.25
Forward PE	38.23
Profit Margin	24.62%
Debt to Equity Ratio	0.29

Volume	674,100
Avg Vol	552,026
Day's Range	N/A - N/A
Shares Out	78.88M
Stochastic %K	15%
Beta	1.58
Analysts	Strong Sell
Price Target	$730.77